Drugs / f-IPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03239496 | Oct 2017 → Nov 2018 | poliomyelitis | Fidec Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | f-IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03239496 ↗ |
| Modality | Vaccine | “fractional dose of inactivated poliovirus vaccine (f-IPV) via intradermal (ID) administration” NCT03239496 ↗ |